Cohen & Steers: Bollinger Bands Narrowing, KDJ Death Cross Triggered on 15min Chart

According to the 15-minute chart provided by Cohen & Steers, there are two notable technical indicators that warrant attention. Firstly, the Bollinger Bands Narrowing indicator suggests that the magnitude of stock price fluctuations is decreasing, indicating a potential for reduced volatility in the near future. Secondly, the KDJ Death Cross at 08/22/2025 15:45 indicates that the momentum of the stock price is shifting towards the downside, which may lead to further decreases in the stock price. Overall, these indicators suggest that the stock price is experiencing a shift in momentum and may be poised for a potential decrease.

According to the 15-minute chart provided by Cohen & Steers, two notable technical indicators have emerged that warrant attention for investors. Firstly, the Bollinger Bands Narrowing indicator suggests that the magnitude of stock price fluctuations is decreasing, indicating a potential for reduced volatility in the near future. Secondly, the KDJ Death Cross at 08/22/2025 15:45 indicates that the momentum of the stock price is shifting towards the downside, which may lead to further decreases in the stock price. Overall, these indicators suggest that the stock price is experiencing a shift in momentum and may be poised for a potential decrease.

The Bollinger Bands Narrowing indicator, a technical analysis tool, shows that the distance between the upper and lower bands of the Bollinger Bands is decreasing. This narrowing often signals a period of lower volatility and can be an early indicator of a potential trend change [1]. The KDJ Death Cross, a significant technical indicator, occurs when the K line (fast stochastic) crosses below the D line (slow stochastic), signaling a potential downward trend [2]. This combination of indicators suggests that Centerspace's stock price may experience reduced volatility and a shift towards a downward trend.

While technical indicators provide valuable insights into potential stock price movements, investors should consider these signals in conjunction with fundamental analysis and broader market conditions. In addition to the technical indicators, several analyst ratings and price targets have been updated recently, offering valuable insights into the potential performance of various stocks [1].

Positive Outlook:
- Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1].
- Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1].
- CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1].
- Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1].
- Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1].
- Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1].
- Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1].
- Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1].
- JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1].
- Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1].
- Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1].
- MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1].
- Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1].
- Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1].
- Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1].
- Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1].
- Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1].
- Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1].
- Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1].
- Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1].
- PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1].
- Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].

References:
[1] https://www.ainvest.com/news/centerspace-15min-chart-shows-kdj-death-cross-bearish-marubozu-2508/